Patent details

Basic Information

Publication number:

EP3344258

PCT Application Number:

US2016052870

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP168494995

PCT Publication Number:

WO2017053416

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATING AUTO-IMMUNE AND AUTO-INFLAMMATORY DISEASES

French Title of Invention:

TRAITEMENT DE MALADIES AUTO-IMMUNES ET DE MALADIES AUTO-INFLAMMATOIRES

German Title of Invention:

BEHANDLUNG VON AUTOIMMUNERKRANKUNGEN UND AUTOENTZÜNDUNGSKRANKHEITEN

SPC Number:

Dates

Filing date:

21/09/2016

Grant date:

10/05/2023

EP Publication Date:

11/07/2018

PCT Publication Date:

30/03/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/05/2023

EP B1 Publication Date:

10/05/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/09/2023

Expiration date:

21/09/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/05/2023

 

 

Name:

Shenzhen Evergreen Therapeutics Co., Ltd.

Address:

62 Guimiao Road Shuntian Tower, Suite 14A Nanshan District, Shenzhen, Guangdong Province 518052, China (CN)

Inventor

1

Name:

LEE, Chang

Address:

United States (US)

2

Name:

DU, Tao, Tom

Address:

United States (US)

Priority

Priority Number:

201514860680

Priority Date:

21/09/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/58; A61K 45/06; A61K 31/57; A61P 11/00; A61P 11/08; A61P 11/06; A61K 9/00;

Publication

European Patent Bulletin

Issue number:

202319

Publication date:

10/05/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages